1. Home
  2. ABCL vs NABL Comparison

ABCL vs NABL Comparison

Compare ABCL & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.21

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$5.25

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
NABL
Founded
2012
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
945.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
NABL
Price
$4.21
$5.25
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$8.40
$8.31
AVG Volume (30 Days)
4.0M
1.0M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
$511,430,000.00
Revenue This Year
N/A
$11.04
Revenue Next Year
$21.85
$8.53
P/E Ratio
N/A
N/A
Revenue Growth
160.56
9.71
52 Week Low
$1.94
$4.15
52 Week High
$6.52
$9.04

Technical Indicators

Market Signals
Indicator
ABCL
NABL
Relative Strength Index (RSI) 70.31 57.81
Support Level $3.91 $4.53
Resistance Level $4.76 $5.44
Average True Range (ATR) 0.21 0.25
MACD 0.05 0.05
Stochastic Oscillator 83.66 85.66

Price Performance

Historical Comparison
ABCL
NABL

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: